Track topics on Twitter Track topics that are important to you
ReNeuron Group has announced that the FDA has approved the cryopreserved formulation of its human retinal progenitor cell (hRPC) therapeutic candidate, which enables it to be frozen for shipping and storage and thawed at the point of clinical use.
Original Article: Cryopreserved formulation of retinal stem cell therapy approved by FDANEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...